MUMBAI, Jan 3 (Reuters) - India’s Jubilant Organosys Ltd. (JUBO.BO: Quote, Profile, Research) said on Tuesday it had entered into a five-year agreement with Eli Lilly & Co. (LLY.N: Quote, Profile, Research) to provide a range of drug discovery services. No other details were available.
